Frank E. Thomas - Jun 1, 2022 Form 4 Insider Report for Orchard Therapeutics plc (ORTX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ORTX	Stock Option (Right to Buy)	Award	$0	+375K		$0.00	375K	Jun 1, 2022	Ordinary Shares	375K	$0.46	Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares subject to this option shall vest and become exercisable in twenty-four (24) equal monthly installments, with the first installment vested on March 1, 2022.
F2	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Title: President & Chief Operating Officer